Search Results For :: internet of medical things
-
Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2030
The global biomaterials market, valued at USD 45.15 billion in 2024, stood at USD 48.36 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of USD 68.93 billion by the end of the period. Biomaterials are specially crafted materials designed to interact safely with biological systems for medical applications.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Electroactive Polymer Market by Type (Conductive Plastic, Inherently Conductive Polymer, Inherently Dissipative Polymer), Application (ESD Protection, EMI Shielding, Actuators, Capacitors, Batteries, Sensors), and Region - Global Forecast to 2022
The electroactive polymers market was valued at USD 3.26 Billion in 2016 and is projected to reach USD 5.12 Billion by 2022, at a CAGR of 7.9% between 2017 and 2022. In this report, 2016 has been considered the base year and the forecast period has been considered from 2017 to 2022. These factors are propelling the demand for electroactive polymers in the region. Solvay (Belgium), Parker Hannifin (US) Agfa-Gevaert (Belgium), 3M (US), Merck (Germany), Lubrizol (US), Novasentis (US), Premix (Finland), and PolyOne Corporation (US), among others, are the key players operating in the electroactive polymers market.
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets – (Pharmaceuticals, Medical devices and Health insurance)
The US healthcare system ranks 37 among health care systems of about 200 worldwide countries ranked by World Health Organization. US health care system is considered as one of the most expensive healthcare system in the world, spending about 16% of its GDP on healthcare. However the rising healthcare costs and increasing health premiums rates along with high number of uninsured people (about 47 million i.e. 16% of the total population) are among the significant factors contributing to the need of health reform in the US. Health reform in the US is looked upon as an initiative towards provision of qualitative and affordable health coverage for all Americans, decrease in rising burden of healthcare costs and improvement in quality & efficiency of health care. Obama has signed health reform in to law, recently in March 2010, to improve the inefficiencies of the existing health care structure. The health reform bill outlays several provisions such as universal health coverage, cost containment, increase in insurance market competition, excise tax on medical device manufacturers and lower drug costs for Medicaid and Medicare are few to mention. Thus the provisions in the health reform directly and indirectly impact the US healthcare/pharmaceutical industry and its stakeholders.
- Published: August 2010
- Price: $ 4950
- TOC Available:
-
BRIC Diagnostic Imaging Equipment Market by Modality ((X-Ray Imaging (Digital, Analog), MRI (High & Low Field), CT (Conventional, CBCT), Nuclear Imaging (SPECT, Hybrid PET)), End User (Hospitals, Imaging Centers) - Global Forecast to 2024
The BRIC diagnostic imaging equipment market is projected to reach USD 8.3 billion by 2024 from USD 5.3 billion in 2019, at a CAGR of 9.2% during the forecast period. The major factors driving the growth of the BRIC diagnostic imaging equipment market include the rising burden of target diseases and increasing investments, funds, and grants for the modernization of imaging facilities. The major players in the market include GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Carestream Health, Inc. (US), Hologic, Inc. (US), Hitachi, Ltd. (Japan), Allengers (India), CURA Healthcare (India), Neusoft Corporation (China), NP JSC Amico (Russia), SONTU Medical Imaging Equipment Co., Ltd. (China), FUJIFILM Holdings Corporation (Japan), and United Imaging Healthcare Co, Ltd. (China), among others.
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Respiratory Care Devices Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings) - Global Forecast to 2030
The global respiratory care devices market, valued at US$22.2 billion in 2024, stood at US$23.6 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Various demographic, medical, and environmental factors propel market growth in respiratory care equipment. Among these is the increase in the global prevalence of respiratory conditions.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
US Neonatal (Preterm) Infant Care Market (2010-2015)
Preterm infant care forms a significant part of the pediatric healthcare market in U.S as preterm births are on a alarming rise in the nation. Preterm births are one of the leading causes of infant mortality in U.S with 1 in 8 births being preterm. Induced fertility and labor treatments, poor prenatal care, inappropriate maternal age, obesity, smoking are some of the major reasons responsible for increasing incidence of preterm births in the country. Preterm infant care products such as infant care devices, infant formula and drugs face a great demand in United States due to the absolute necessity of such products in sustaining baby lives. The products are indispensable in saving preterm babies because they are biologically immature and require external medical assistance in the form of respiratory, nutritional and thermal control support for survival. Infant care products have helped to increase the survival of preterm babies in the country. The criticality of the products in preterm infant care is driving the market. Furthermore, technology advances in regards to multi function equipments are also propelling the growth of the market.
- Published: March 2011
- Price: $ 4950
- TOC Available:
-
Global Weight Loss and Diet Management Market (2009 - 2014)
Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition.
- Published: July 2009
- Price: $ 4950
- TOC Available:
-
Global Waste-To-Energy Market By Geography, Technology, Applications Market Trends And Forecasts
Waste-to-energy (WtE) is the process wherein waste is treated to generate energy. This report looks at the WtE current and emerging technologies, key players in the market and the commercialization of such technologies.
- Published: March 2011
- Price: $ 4950
- TOC Available:
-
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Immunoassay, NGS, PCR, Microscopy), Application (Diagnostic, Clinical), End User (Pharma, Agriculture & Food Industry, Hospital, Diagnostic Lab) - Global Forecasts to 2031
The global Life Science Instrumentation market, valued at US$59.9 billion in 2024, stood at US$63.4 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2030, culminating in a forecasted valuation of US$92.5 billion by the end of the period. The main drivers of the life science instrumentation market include increasing demand for advanced analytical technologies in drug discovery, genomics, and proteomics research, along with rising investments in pharmaceutical and biotechnology R&D.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Bioinformatics Market by Product & Service (Knowledge Management Tools, Bioinformatics Platforms, Data Analysis, Structural Analysis, Services), Applications (Genomics, Proteomics, Transcriptomics), Sectors (Medical, Animal) & Region - Global Forecast to 2027
The global bioinformatics market in terms of revenue was estimated to be worth $10.1 billion in 2022 and is poised to reach $18.7 billion by 2027, growing at a CAGR of 13.0% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: December 2022
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 54
